We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-3.31%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$2.38B
AUM Growth
+$407M
Cap. Flow
+$540M
Cap. Flow %
22.68%
Top 10 Hldgs %
32.09%
Holding
169
New
35
Increased
72
Reduced
38
Closed
24

Top Sells

Rank Stock Value
1
COUR icon
Coursera
COUR
+$25.2M
2
APP icon
Applovin
APP
+$22.4M
3
CTSH icon
Cognizant
CTSH
+$20.7M
4
CPAY icon
Corpay
CPAY
+$19.5M
5
AKAM icon
Akamai
AKAM
+$18.1M

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Communication Services 13.73%
3 Healthcare 12.21%
4 Consumer Discretionary 11.73%
5 Energy 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KFY icon
126
Korn Ferry
KFY
$4.3B
$2.09M 0.09%
44,010
+1,109
+3% +$56.3K
NDLS icon
127
Noodles & Co
NDLS
$96M
$2.07M 0.09%
+105,431
New +$2.54M
ECHO
128
EchoStar
ECHO
$25.9B
$1.9M 0.08%
113,250
+2,742
+2% +$51.8K
FONR
129
DELISTED
Fonar
FONR
$1.87M 0.08%
121,547
+5,145
+4% +$85K
INGN icon
130
Inogen
INGN
$160M
$1.77M 0.07%
339,843
-39,411
-10% -$280K
XYZ
131
Block Inc
XYZ
$47.5B
$1.76M 0.07%
+39,695
New +$2.46M
ANIK icon
132
Anika Therapeutics
ANIK
$277M
$1.74M 0.07%
+93,653
New +$1.94M
AAP icon
133
Advance Auto Parts
AAP
$3.36B
$1.66M 0.07%
+29,598
New +$1.98M
CSTE icon
134
Caesarstone
CSTE
$88.2M
$1.6M 0.07%
372,756
+15,609
+4% +$75.2K
FORR icon
135
Forrester Research
FORR
$221M
$1.39M 0.06%
48,267
-76,046
-61% -$2.34M
SA
136
Seabridge Gold
SA
$3.36B
$1.32M 0.06%
125,379
+3,019
+2% +$35.8K
MAGN
137
Magnera Corp
MAGN
$466M
$1.29M 0.05%
49,572
+28,610
+136% +$952K
TPIC
138
DELISTED
TPI Composites
TPIC
$1.28M 0.05%
+481,222
New +$2.94M
ASTL icon
139
Algoma Steel
ASTL
$468M
$1.15M 0.05%
169,021
-5,836
-3% -$41.9K
PHX
140
DELISTED
PHX Minerals
PHX
$1.05M 0.04%
288,959
+12,563
+5% +$42.2K
ZD icon
141
Ziff Davis
ZD
$2B
$1.02M 0.04%
16,051
-558
-3% -$38.3K
TWKS
142
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$913K 0.04%
+223,770
New +$1.27M
LEXX icon
143
Lexaria Bioscience
LEXX
$9.07M
$764K 0.03%
50,955
-150
-0.3% -$2.06K
CVEO icon
144
Civeo
CVEO
$330M
$762K 0.03%
36,782
-1,256
-3% -$24.4K
BHR
145
Braemar Hotels & Resorts
BHR
$139M
$292K 0.01%
+105,327
New +$327K
AKAM icon
146
Akamai
AKAM
$16.9B
-201,145
Closed -$18.1M
AMPL icon
147
Amplitude
AMPL
$1.52B
-163,672
Closed -$1.8M
BHE icon
148
Benchmark Electronics
BHE
$2.92B
-96,552
Closed -$2.49M
BV icon
149
BrightView Holdings
BV
$1.05B
-179,156
Closed -$1.29M
CASS icon
150
Cass Information Systems
CASS
$734M
-56,535
Closed -$2.19M

Similar funds

Invenomic Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Invenomic Capital Management held 169 positions worth $2.38B, up 21% from $1.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Invenomic Capital Management deployed $540M of net new capital in Q3 2023, opening 35 new positions and adding to 72 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 550,000 shares worth $235M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Applovin, an estimated $22.4M trimmed.

  • Invenomic Capital Management's largest Q3 2023 buy was State Street SPDR S&P 500 ETF Trust: 550,000 shares worth $235M.
  • Invenomic Capital Management added most to Citigroup in Q3 2023, an estimated $37.9M increase.
  • Invenomic Capital Management's biggest Q3 2023 reduction was Applovin, cutting an estimated $22.4M.
  • Invenomic Capital Management fully exited Coursera in Q3 2023, selling an estimated $25.2M.
  • Invenomic Capital Management's ten largest holdings make up 32% of its $2.38B portfolio in Q3 2023.
  • Invenomic Capital Management opened 35 new positions and closed 24 in Q3 2023.
  • Invenomic Capital Management's portfolio value rose 21% quarter-over-quarter to $2.38B.

Based on Invenomic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.